<DOC>
	<DOCNO>NCT00356057</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness biventricular pace conventional right ventricular pace patient persistent permanent , symptomatic atrial fibrillation undergo atrioventricular ( AV ) node ablation permanent pacing therapy .</brief_summary>
	<brief_title>Investigational Device Exemption ( IDE ) Study Approval Closed Loop Stimulation ( CLS ) Cardiac Resyncronization Pacing Therapies ( CRT ) Treatment Atrial Fibrillation ( AF ) With Ablate Pace</brief_title>
	<detailed_description>This study multi-center , prospective , randomize , blind trial . The study consist approximately 265 patient require treatment persistent permanent , symptomatic atrial fibrillation atrioventricular ( AV ) node ablation permanent pace therapy i.e . `` Ablate Pace '' therapy . All patient enrol clinical study randomly assign one three group use randomization ratio 2:2:1 . Patients assign receive either biventricular ( biV ) pace CLS-based rate adaptive pacing use legally market Protos DR/CLS ( Group 1 ) , biventricular pace accelerometer-based rate adaptive pacing use Stratos LV ( Group 2 ) , right ventricular ( RV ) pace accelerometer-based rate adaptive pacing use Stratos LV ( Group 3 ) . Patients three group implant legally market right leave ventricular pacing lead . The patient , core lab use interpret echocardiographic data Clinical Events Committee adjudicate crossover , patient death congestive heart failure ( CHF ) hospitalization blind randomization assignment .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Meet indication therapy Persistent , symptomatic AF poorly control rapid ventricular rate permanent , symptomatic AF poorly control rapid ventricular rate . Eligible AV nodal ablation permanent pacemaker implantation NYHA Class II III heart failure Age â‰¥ 18 year Understand nature procedure Ability tolerate surgical procedure require implantation Give inform consent Able complete testing require clinical protocol Available followup visit regular basis investigational site Meet one contraindication Have life expectancy less six month Expected receive heart transplantation within six month Enrolled another cardiovascular pharmacological clinical investigation Patients ICD , consider ICD Patients previously implant biventricular pace system Patients previously implant single dual chamber pace system &gt; 50 % document ventricular pacing Patients previous AV node ablation Sixminute walk test distance great 450 meter Any condition prevent patient able perform require test Presence another lifethreatening , underlie illness separate cardiac disorder Conditions prohibit placement lead system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>AV node ablation</keyword>
	<keyword>pacemaker</keyword>
	<keyword>congestive heart failure</keyword>
</DOC>